Open Access

Molecular Oncology

, volume 15 , issue 12 , pages 3242-3255

Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer

Cecilia R Chambers ^{1, 2}

Shona Ritchie ^{1, 2}

Brooke A. Pereira ^{1, 2}

Paul Timpson ^{1, 2}

Hide authors affiliations Show authors affiliations: 2 affiliations

Garvan Institute of Medical Research The Kinghorn Cancer Centre Sydney NSW Australia |

Faculty of Medicine St. Vincent's Clinical School University of New South Wales Sydney NSW Australia |

Publication type: Journal Article

Publication date: 2021-07-12

Wiley

Molecular Oncology

scimago Q1

wos Q2

SJR: 1.957

CiteScore: 11.4

Impact factor: 4.5

ISSN: 15747891, 18780261

DOI: 10.1002/1878-0261.13042

Copy DOI

PubMed ID: 34137158

Cancer Research

Oncology

General Medicine

Genetics

Molecular Medicine

Found

1 citation

Takefuji Yoshiyasu

240 publications, 399 citations, 39 reviews

Artificial intelligence

Data Science

Internet of Things (IoTs)

Top-30

Journals

	1 2 3 4 5
Cancers	Cancers, 5, 4.31% Cancers 5 publications, 4.31%
Frontiers in Oncology	Frontiers in Oncology, 5, 4.31% Frontiers in Oncology 5 publications, 4.31%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 4, 3.45% International Journal of Molecular Sciences 4 publications, 3.45%
Cells	Cells, 4, 3.45% Cells 4 publications, 3.45%
Frontiers in Cardiovascular Medicine	Frontiers in Cardiovascular Medicine, 3, 2.59% Frontiers in Cardiovascular Medicine 3 publications, 2.59%
Frontiers in Cell and Developmental Biology	Frontiers in Cell and Developmental Biology, 3, 2.59% Frontiers in Cell and Developmental Biology 3 publications, 2.59%
Ageing Research Reviews	Ageing Research Reviews, 3, 2.59% Ageing Research Reviews 3 publications, 2.59%
Frontiers in Immunology	Frontiers in Immunology, 2, 1.72% Frontiers in Immunology 2 publications, 1.72%
International Journal of Cancer	International Journal of Cancer, 2, 1.72% International Journal of Cancer 2 publications, 1.72%
Biomedicines	Biomedicines, 2, 1.72% Biomedicines 2 publications, 1.72%
Seminars in Cancer Biology	Seminars in Cancer Biology, 2, 1.72% Seminars in Cancer Biology 2 publications, 1.72%
Inflammopharmacology	Inflammopharmacology, 2, 1.72% Inflammopharmacology 2 publications, 1.72%
Molecular Cancer	Molecular Cancer, 2, 1.72% Molecular Cancer 2 publications, 1.72%
Plastic and Reconstructive Surgery	Plastic and Reconstructive Surgery, 1, 0.86% Plastic and Reconstructive Surgery 1 publication, 0.86%
Nutrients	Nutrients, 1, 0.86% Nutrients 1 publication, 0.86%
Frontiers in Physiology	Frontiers in Physiology, 1, 0.86% Frontiers in Physiology 1 publication, 0.86%
Oncology Research	Oncology Research, 1, 0.86% Oncology Research 1 publication, 0.86%
Cellular and Molecular Biology Letters	Cellular and Molecular Biology Letters, 1, 0.86% Cellular and Molecular Biology Letters 1 publication, 0.86%
Free Radical Biology and Medicine	Free Radical Biology and Medicine, 1, 0.86% Free Radical Biology and Medicine 1 publication, 0.86%
Cancer Medicine	Cancer Medicine, 1, 0.86% Cancer Medicine 1 publication, 0.86%
Expert Review of Anticancer Therapy	Expert Review of Anticancer Therapy, 1, 0.86% Expert Review of Anticancer Therapy 1 publication, 0.86%
Molecules and Cells	Molecules and Cells, 1, 0.86% Molecules and Cells 1 publication, 0.86%
Journal of Oncology	Journal of Oncology, 1, 0.86% Journal of Oncology 1 publication, 0.86%
American Journal of Physiology - Cell Physiology	American Journal of Physiology - Cell Physiology, 1, 0.86% American Journal of Physiology - Cell Physiology 1 publication, 0.86%
Interdisciplinary Cancer Research	Interdisciplinary Cancer Research, 1, 0.86% Interdisciplinary Cancer Research 1 publication, 0.86%
Current Urology	Current Urology, 1, 0.86% Current Urology 1 publication, 0.86%
British Journal of Haematology	British Journal of Haematology, 1, 0.86% British Journal of Haematology 1 publication, 0.86%
Annals of Translational Medicine	Annals of Translational Medicine, 1, 0.86% Annals of Translational Medicine 1 publication, 0.86%
Computational and Structural Biotechnology Journal	Computational and Structural Biotechnology Journal, 1, 0.86% Computational and Structural Biotechnology Journal 1 publication, 0.86%
	1 2 3 4 5

Publishers

	5 10 15 20 25
MDPI	MDPI, 21, 18.1% MDPI 21 publications, 18.1%
Springer Nature	Springer Nature, 20, 17.24% Springer Nature 20 publications, 17.24%
Elsevier	Elsevier, 20, 17.24% Elsevier 20 publications, 17.24%
Frontiers Media S.A.	Frontiers Media S.A., 16, 13.79% Frontiers Media S.A. 16 publications, 13.79%
Wiley	Wiley, 14, 12.07% Wiley 14 publications, 12.07%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 3, 2.59% Cold Spring Harbor Laboratory 3 publications, 2.59%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 2, 1.72% Ovid Technologies (Wolters Kluwer Health) 2 publications, 1.72%
Taylor & Francis	Taylor & Francis, 2, 1.72% Taylor & Francis 2 publications, 1.72%
Spandidos Publications	Spandidos Publications, 2, 1.72% Spandidos Publications 2 publications, 1.72%
Oxford University Press	Oxford University Press, 2, 1.72% Oxford University Press 2 publications, 1.72%
	, 1, 0.86% 1 publication, 0.86%
Hindawi Limited	Hindawi Limited, 1, 0.86% Hindawi Limited 1 publication, 0.86%
American Physiological Society	American Physiological Society, 1, 0.86% American Physiological Society 1 publication, 0.86%
S. Karger AG	S. Karger AG, 1, 0.86% S. Karger AG 1 publication, 0.86%
AME Publishing Company	AME Publishing Company, 1, 0.86% AME Publishing Company 1 publication, 0.86%
Walter de Gruyter	Walter de Gruyter, 1, 0.86% Walter de Gruyter 1 publication, 0.86%
Pleiades Publishing	Pleiades Publishing, 1, 0.86% Pleiades Publishing 1 publication, 0.86%
SPb RAACI	SPb RAACI, 1, 0.86% SPb RAACI 1 publication, 0.86%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 1, 0.86% American Association for the Advancement of Science (AAAS) 1 publication, 0.86%
The Russian Academy of Sciences	The Russian Academy of Sciences, 1, 0.86% The Russian Academy of Sciences 1 publication, 0.86%
Japanese Society for Dental Materials and Devices	Japanese Society for Dental Materials and Devices, 1, 0.86% Japanese Society for Dental Materials and Devices 1 publication, 0.86%
IGI Global	IGI Global, 1, 0.86% IGI Global 1 publication, 0.86%
American Chemical Society (ACS)	American Chemical Society (ACS), 1, 0.86% American Chemical Society (ACS) 1 publication, 0.86%
Zhejiang University Press	Zhejiang University Press, 1, 0.86% Zhejiang University Press 1 publication, 0.86%
	5 10 15 20 25

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

PDF

Metrics

116

Cite this

GOST |

Cite this

GOST Copy

Chambers C. R. et al. Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer // Molecular Oncology. 2021. Vol. 15. No. 12. pp. 3242-3255.

GOST all authors (up to 50) Copy

Chambers C. R., Ritchie S., Pereira B. A., Timpson P. Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer // Molecular Oncology. 2021. Vol. 15. No. 12. pp. 3242-3255.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1002/1878-0261.13042

UR - https://doi.org/10.1002/1878-0261.13042

TI - Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer

T2 - Molecular Oncology

AU - Chambers, Cecilia R

AU - Ritchie, Shona

AU - Pereira, Brooke A.

AU - Timpson, Paul

PY - 2021

DA - 2021/07/12

PB - Wiley

SP - 3242-3255

IS - 12

VL - 15

PMID - 34137158

SN - 1574-7891

SN - 1878-0261

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2021_Chambers,

author = {Cecilia R Chambers and Shona Ritchie and Brooke A. Pereira and Paul Timpson},

title = {Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer},

journal = {Molecular Oncology},

year = {2021},

volume = {15},

publisher = {Wiley},

month = {jul},

url = {https://doi.org/10.1002/1878-0261.13042},

number = {12},

pages = {3242--3255},

doi = {10.1002/1878-0261.13042}

}

MLA

Cite this

MLA Copy

Chambers, Cecilia R., et al. “Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.” Molecular Oncology, vol. 15, no. 12, Jul. 2021, pp. 3242-3255. https://doi.org/10.1002/1878-0261.13042.

Publisher

Wiley

Journal

Molecular Oncology

scimago Q1

wos Q2

SJR

1.957

CiteScore

11.4

Impact factor

4.5

ISSN

15747891 (Print)

18780261 (Electronic)